Last edition
News about Drug Discovery & Development
Cipla Gets Final FDA Approval for Lanreotide Injection
Cipla Ltd. has received the final approval for its Abbreviated New Drug Application (ANDA) for Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL from the United States Food and Drug Administration (US FDA).
Drug Discovery & Development | 23/05/2024 | By Aishwarya | 1599
Galapagos, BCA to Boost Decentralized CAR-T Manufacturing Network in US
Galapagos has inked a strategic partnership with Blood Centers of America (BCA) for the decentralized manufacturing of Galapagos’ CAR-T cell therapies through BCA’s network in the US.
Drug Discovery & Development | 17/05/2024 | By Aishwarya | 333
Venous thromboembolism (VTE) is a significant medical condition characterized by the formation of blood clots within the deep venous system.
Drug Discovery & Development | 16/05/2024 | By Manvi | 620
CASI Pharmaceuticals Advances CID-103 into Clinical Development for Chronic Immune Thrombocytopenia
CASI received a letter from the FDA indicating clearance for the study to proceed, signaling regulatory approval for the advancement of CID-103 into clinical trials.
Drug Discovery & Development | 16/05/2024 | By Abha | 760
Roquette Unveils New LYCAGEL Flex Softgel Capsule Shell System
Roquette has developed its new LYCAGEL Flex hydroxypropyl pea starch premix for nutraceutical and pharmaceutical softgel capsules.
Drug Discovery & Development | 15/05/2024 | By Aishwarya | 476
Sartorius, Sanofi to Develop End-to-End Platform for Downstream Process Intensification
Sartorius has joined hands with Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing.
Drug Discovery & Development | 14/05/2024 | By Aishwarya | 939
Fulcrum Signs License Deal with Sanofi for Development of Losmapimod in FSHD
Fulcrum Therapeutics has entered into a collaboration and license agreement with Sanofi for the development and commercialization of losmapimod.
Drug Discovery & Development | 14/05/2024 | By Aishwarya | 430
The Jackson Laboratory and AbTherx to Boost Therapeutic Antibody Discovery
The Jackson Laboratory (JAX) has forged a strategic partnership with AbTherx to develop and commercialize cutting-edge tools to expedite antibody discovery and derisk the development of vital new therapies.
Drug Discovery & Development | 13/05/2024 | By Aishwarya | 642
Ribobay Pharma Offers oligo CRDMO Services with Cytiva FlexFactory Platform
Ribobay Pharma has announced that it will provide cGMP-level oligonucleotide (oligo) CRDMO services to the world using Cytiva's first FlexFactory platform for oligo manufacturing.
Drug Discovery & Development | 13/05/2024 | By Aishwarya | 466
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
The Vertex HFN offers an innovative approach to fracture fixation, aiming to enhance patient outcomes and streamline surgical procedures.
Drug Discovery & Development | 10/05/2024 | By Manvi | 517
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy